Genomic expression and single-nucleotide polymorphism profiling discriminates chromophobe renal cell carcinoma and oncocytoma

scientific article

Genomic expression and single-nucleotide polymorphism profiling discriminates chromophobe renal cell carcinoma and oncocytoma is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1051996740
P356DOI10.1186/1471-2407-10-196
P932PMC publication ID2883967
P698PubMed publication ID20462447
P5875ResearchGate publication ID44592097

P50authorBernard DebréQ2897761
Nicolas ThiounnQ114434176
Annick VieillefondQ114718325
Bin Tean TehQ47451223
P2093author name stringMin-Han Tan
Tomoaki Fujioka
Stéphane Richard
Kyle A Furge
Ximing J Yang
Philippe Vielh
Daisuke Matsuda
Delphine Amsellem-Ouazana
Marc Zerbib
Thierry Flam
Puay Hoon Tan
Eric Kort
Sophie Giraud
Stéphane Droupy
Gérard Benoît
Sophie Ferlicot
Sok Kean Khoo
Vincent Molinié
Jun Sugimura
Jonathon Ditlev
Chin Fong Wong
Hwei Ling Tan
P2860cites workDetection of a germline mutation and somatic homozygous loss of the von Hippel-Lindau tumor-suppressor gene in a family with a de novo mutation. A combined genetic study, including cytogenetics, PCR/SSCP, FISH, and CGH.Q48063955
Colloidal iron staining in renal epithelial neoplasms, including chromophobe renal cell carcinoma: emphasis on technique and patterns of staining.Q50524825
Birt-Hogg-Dubé syndrome: mapping of a novel hereditary neoplasia gene to chromosome 17p12-q11.2.Q55035109
Detection of a germline mutation and somatic homozygous loss of the von Hippel-Lindau tumor-suppressor gene in a family with a de novo mutationQ57631389
HER-2/neu is expressed in human renal cell carcinoma at heterogeneous levels independently of tumor grading and staging and can be recognized by HLA-A2.1-restricted cytotoxic T lymphocytesQ74009000
Sporadic human renal tumors display frequent allelic imbalances and novel mutations of the HRPT2 geneQ79387201
Analysis of chromosome 1p abnormalities in renal oncocytomas by loss of heterozygosity studies: correlation with conventional cytogenetics and fluorescence in situ hybridizationQ80732556
Bioconductor: open software development for computational biology and bioinformaticsQ21194861
Parafibromin/Hyrax activates Wnt/Wg target gene transcription by direct association with beta-catenin/ArmadilloQ24319343
Significance analysis of microarrays applied to the ionizing radiation responseQ24606608
Aquaporin-6: An intracellular vesicle water channel protein in renal epitheliaQ28118403
Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dubé syndromeQ28219681
Characterization of synaptogyrin 3 as a new synaptic vesicle proteinQ28591906
Diagnosis of multiple cancer types by shrunken centroids of gene expressionQ29615528
Temsirolimus, interferon alfa, or both for advanced renal-cell carcinomaQ29618608
Robust classification of renal cell carcinoma based on gene expression data and predicted cytogenetic profilesQ30939032
Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinomaQ34533170
A molecular classification of papillary renal cell carcinomaQ34558981
Gene expression profiling separates chromophobe renal cell carcinoma from oncocytoma and identifies vesicular transport and cell junction proteins as differentially expressed genes.Q34587288
Molecular classification of renal tumors by gene expression profilingQ35789932
Gene expression profiling of renal cell carcinomaQ35901583
Metastatic renal oncocytomaQ35954313
Parafibromin expression in breast cancer: a novel marker for prognostication?Q38432689
Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroid carcinomaQ40505781
An integrated view of copy number and allelic alterations in the cancer genome using single nucleotide polymorphism arraysQ40559185
The human chromophobe cell renal carcinoma: its probable relation to intercalated cells of the collecting ductQ41276062
Molecular differential diagnosis of renal cell carcinomas by microsatellite analysisQ42803057
Molecular subclassification of kidney tumors and the discovery of new diagnostic markersQ44615414
Transcriptional profiling reveals coordinated up-regulation of oxidative metabolism genes in thyroid oncocytic tumorsQ44757199
Clonal expansion of mutated mitochondrial DNA is associated with tumor formation and complex I deficiency in the benign renal oncocytomaQ46835332
P407language of work or nameEnglishQ1860
P921main subjectsingle-nucleotide polymorphismQ501128
chromophobe renal cell carcinomaQ18556342
P304page(s)196
P577publication date2010-05-12
P1433published inBMC CancerQ326300
P1476titleGenomic expression and single-nucleotide polymorphism profiling discriminates chromophobe renal cell carcinoma and oncocytoma
P478volume10

Reverse relations

cites work (P2860)
Q49425132A miRNA-based classification of renal cell carcinoma subtypes by PCR and in situ hybridization
Q64963357Allele Loss and Reduced Expression of CYCLOPS Genes is a Characteristic Feature of Chromophobe Renal Cell Carcinoma.
Q51112302Aquaporins in Urinary System.
Q41626040Characteristics of the Peritumoral Pseudocapsule Vary Predictably With Histologic Subtype of T1 Renal Neoplasms
Q43127635Chromophobe renal cell carcinoma, eosinophilic variant with papillary growth: a case report
Q46570230Chromophobe renal cell carcinoma--chromosomal aberration variability and its relation to Paner grading system: an array CGH and FISH analysis of 37 cases.
Q95658401Chromophobe renal cell carcinoma: New genetic and metabolic insights
Q38020180Chromophobe renal cell carcinoma: a review of an uncommon entity
Q61810692Chromosomal aberrations in renal cell carcinoma: An overview with implications for clinical practice
Q27023770Circulating biomarkers in advanced renal cell carcinoma: clinical applications
Q33745315Constitutive patterns of gene expression regulated by RNA-binding proteins
Q83761819Copy number profiling in von Hippel-Lindau disease renal cell carcinoma
Q26752381Current Insights into Long Non-Coding RNAs in Renal Cell Carcinoma
Q89184091Cytogenetic and immunohistochemical study of 42 pigmented microcystic chromophobe renal cell carcinoma (PMChRCC)
Q34253377DNA methylation profiles delineate etiologic heterogeneity and clinically important subgroups of bladder cancer
Q36891899DNA methylation profiling distinguishes histological subtypes of renal cell carcinoma.
Q41192211Distinct Cytoplasmic Expression of KL-6 Mucin in Chromophobe Renal Cell Carcinoma: A Comparative Immunohistochemical Study with Other Renal Epithelial Cell Tumors
Q38471131Expression analysis of the estrogen receptor target genes in renal cell carcinoma
Q41766499Expression of parafibromin in major renal cell tumors
Q36640781Genetic alterations of HER genes in chromophobe renal cell carcinoma
Q26785930Genetic and Chromosomal Aberrations and Their Clinical Significance in Renal Neoplasms
Q34295804Genome haploidisation with chromosome 7 retention in oncocytic follicular thyroid carcinoma.
Q50959212Hybrid oncocytic/chromophobe renal cell tumours do not display genomic features of chromophobe renal cell carcinomas.
Q92969752Hybrid oncocytic/chromophobe renal tumors are molecularly distinct from oncocytoma and chromophobe renal cell carcinoma
Q47104226Identification and validation of a 44-gene expression signature for the classification of renal cell carcinomas
Q93055320Identification of Key Genes and Prognostic Analysis between Chromophobe Renal Cell Carcinoma and Renal Oncocytoma by Bioinformatic Analysis
Q37114357Insights into the Genetic Basis of the Renal Cell Carcinomas from The Cancer Genome Atlas
Q57645130Mitochondria with tubulovesicular cristae in renal oncocytomas
Q92442627Molecular Genetics of Renal Cell Tumors: A Practical Diagnostic Approach
Q33982903Molecular sub-classification of renal epithelial tumors using meta-analysis of gene expression microarrays.
Q51504223Morphological, immunohistochemical, and chromosomal analysis of multicystic chromophobe renal cell carcinoma, an architecturally unusual challenging variant.
Q36693159Multilevel Genomics-Based Taxonomy of Renal Cell Carcinoma
Q36182819Non-clear cell renal cell carcinoma: does the mammalian target of rapamycin represent a rational therapeutic target?
Q37836508Non-clear cell renal cell carcinoma: how new biological insight may lead to new therapeutic modalities
Q96132776Optimal Management of First-Line Advanced Renal Cell Carcinoma: Focus on Pembrolizumab
Q30248354Renal cell cancer: overview of the current therapeutic landscape.
Q24630685State of the science: an update on renal cell carcinoma
Q27013846Targeted therapeutic strategies for the management of renal cell carcinoma
Q38858757The clinicopathological significances and biological functions of parafibromin expression in head and neck squamous cell carcinomas
Q90720037Transcriptomics in RCC